Attached files
| file | filename |
|---|---|
| EX-99.1 - LETTER OF RESIGNATION - AIkido Pharma Inc. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
____________________________________________________________
Date of Report (Date of earliest event reported): May 28, 2014
SPHERIX INCORPORATED
(Exact Name of Registrant as Specified in Charter)
|
Delaware
|
0-5576
|
52-0849320
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
6430 Rockledge Drive, Suite 503 Bethesda, MD
|
20817
|
|||
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (703) 992-9260
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On May 28, 2014, Harvey Kesner resigned as a director of the company. Mr. Kesner was appointed as a director and had been appointed interim chief executive officer in February 2013. Mr. Kesner led the company’s restructuring efforts. Mr. Kesner’s decision to resign from the board was not the result of any dispute or disagreement with the Company.
|
ITEM 9.01
|
Financial Statements and Exhibits.
|
|
Exhibit no.
|
Description
|
|
99.1
|
Letter of Resignation
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: May 28, 2014
|
SPHERIX INCORPORATED
|
|
|
By:
|
/s/ Anthony Hayes
|
|
Name: Anthony Hayes
|
|
|
Title: Chief Executive Officer
|
|